Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit

Author： Brugts Jasper J   Boersma Eric   Simoons Maarten L  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.8, 2010-08, pp. : 1115-1126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

By Brugts J.   Maat M.   Boersma E.   Witteman J.   Duijn C.   Uitterlinden A.   Bertrand M.   Remme W.   Fox K.   Ferrari R.   Danser A.   Simoons M.  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 171-181

Springer Publishing Company

Access to resources Recommend Favorite

Revascularization treatment of stable coronary artery disease

By Magro Michael   Garg Scot   Serruys Patrick W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 195-212

Informa Healthcare

Access to resources Recommend Favorite

Roxifiban promising in stable coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Novel Anti-Platelets in Stable Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4537-4567

Bentham Science Publishers

Access to resources Recommend Favorite

Improvement in Endothelial Progenitor Cells from Peripheral Blood by Ramipril Therapy in Patients with Stable Coronary Artery Disease

By Min Tao Qian   Zhu Chen Jun   Xiang Wang Xing   Hui Zhu Jun   Peng Shang Yun  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 3, 2004-05 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite